Company Name
Zhejiang Kangle Capsule Co., Ltd.
Year of Establishment
1980
Annual Turnover(USD)
500,000 to 99,999,999
Company Introduction
Zhejiang Kang Le Capsule Co., Ltd. was founded in 1980. Currently, our company has newly acquired over 8,000 square meters of land in the Xinchang County Capsule Industrial Park beside National Highway 104, with an investment of over 10 million yuan. The factory buildings are all designed and constructed in accordance with GMP requirements, and the annual output of pharmaceutical hollow capsules reaches 12 billion.
The company is located in a beautiful environment with convenient transportation, enjoying unique production conditions. As a key private joint-stock enterprise in Zhejiang Province and a backbone enterprise in the "hometown of capsules" in China, we hold a Drug Production License (ZheJ20000237) and National Medicine Approval Number (F20020048). With a long history, advanced equipment and strong technical strength, we provide customers with empty capsules of various specifications and colors such as 00#, 0#, 1#, 2#, 3#, 4#, as well as axial, circumferential and directional two-color printed capsules.
The building area of the factory is over 6,000 square meters, and the storage area is 1,000 square meters. The cleanliness level of the production workshop reaches above 100,000. The company currently has 150 employees, of whom those with junior college education or above account for 20%. We fully implement quality management and have won honors such as "Private Joint-stock Enterprise with a Large Tax Payment".
Our quality policy is: "Always customer-centered, with the Drug Administration Law as the criterion, involve all staff in quality management, improve product quality, make continuous improvements, meet customer needs, and ensure that every empty capsule of our company is qualified."
Our purpose is: "Focusing on customers, with quality first and reputation supreme. Your satisfaction is our only pursuit."
Zhejiang Kang Le Capsule Co., Ltd. will join hands with domestic and foreign pharmaceutical enterprises with excellent product quality, reasonable prices and high-quality after-sales service. We sincerely look forward to cooperating with you to create a better future! If you have any needs, please feel free to contact us.
Main Competitive Advantages
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service,
Website
www.kanglecapsule.com
Other Competitive Advantages
Advanced production equipment and technology: The company owns advanced production equipment and a strict quality management system, ensuring high quality and consistency of products. The production lines adopt automation and intelligent technologies, enhancing production efficiency and product stability.
Strict quality control and compliance: The company has passed international certifications such as ISO9001 and GMP, ensuring product quality and compliance of the production process. The strict quality control system guarantees the safety and effectiveness of each capsule.
Rich industry experience and market recognition: As a key private joint-stock enterprise in Zhejiang Province and a backbone enterprise in the "hometown of capsules" in China, the company enjoys high popularity and market recognition in the industry and has accumulated rich customer resources and cooperation experience.
Environmental protection and sustainable development: The company attaches great importance to environmental protection and sustainable development, actively investing in the construction of environmental protection facilities to reduce pollution in the production process, meeting the requirements of modern corporate social responsibility.
Strong supply chain and logistics capabilities: The company has a complete supply chain management and logistics system, capable of ensuring timely product delivery to meet customers' urgent needs.
Innovation ability and technical reserves: The company continuously carries out technological innovation and product upgrades, possessing a strong R & D team and technical reserves, enabling it to quickly respond to market changes and customer demands.
Employee training and development: The company cares about employee welfare, providing a good working environment and training opportunities to promote employee growth, thus forming a stable and competitive team.
Patents and Copyright
Utility Model Patents
The utility model patent of “a plant empty capsule” with the patent number ZL202222395483.2.
The utility model patent of “An enteric-soluble empty capsule” with the patent number ZL202222384214.6.
Invention Patents
The invention patent titled “The invention discloses a capsule screening equipment” with the patent number ZL201711429195.1.
The invention patent titled “The invention relates to a glue drying sterilization device” with the patent number ZL201711449648.7.
Milestone
Foundation and Establishment Period (1980 - 1990)
1980
Xinchang Kangle Capsule Co., Ltd. was officially established, marking the beginning of the company's development journey. In the early days of its establishment, leveraging its keen insight into the rich local pharmaceutical resources and traditional pharmaceutical culture in Xinchang, the company determined its focus on the production of hollow capsules. At that time, despite having rudimentary equipment and a small scale, with the passion for entrepreneurship and a persistent pursuit of quality, the company embarked on a challenging start-up journey.
1985
A stable production process was initially established. This achievement marked a solid first step in the field of hollow capsule manufacturing. The products began to be supplied to some local small pharmaceutical enterprises on a small scale, gradually accumulating reputation and market trust.
1990
The number of company employees exceeded 30, and the area of the production workshop doubled. During this period, the company began to focus on the construction of a quality management system and introduced basic quality inspection procedures to ensure that product quality met the industry standards at that time, laying a solid foundation for subsequent development.
II. Growth and Expansion Period (1991 - 2005)
1995
With the gradual expansion of the domestic pharmaceutical market, the company seized the opportunity and carried out its first equipment upgrade and transformation. It introduced relatively advanced hollow capsule production lines at that time, increasing the annual production capacity to 3 billion capsules and expanding the product range to 5 specifications. This move significantly enhanced the company's market competitiveness, and its products began to enter the markets of pharmaceutical enterprises in surrounding provinces.
2000
The company was officially renamed Zhejiang Kangle Capsule Co., Ltd. This name change was not only a change in the name but also a sign of the company's strategic transformation and brand upgrading. The company increased its investment in research and development and formed its own R & D team, dedicated to improving product quality and performance. In the same year, the company obtained a Drug Production License (ZheJ20000237), which was a high recognition of the company's production qualifications and quality management level.
2003
Against the backdrop of increasingly fierce competition in the national pharmaceutical industry, the company decided to relocate to the Xinchang County Capsule Industrial Park, acquiring more than 8,000 square meters of new land and investing over 10 million yuan to build a new factory. The new factory was designed and constructed in accordance with GMP requirements, with a cleanliness level reaching above 100,000, a major move that brought the company's production environment and facilities to a leading level in China, providing a strong guarantee for producing high-quality hollow capsules.
2005
The company's annual production capacity exceeded 8 billion capsules, the product specifications increased to 8 types, and it began to venture into the production of colored hollow capsules. Meanwhile, the company actively carried out marketing activities, established its own sales team, and expanded customer resources across the country, with its market share increasing year by year.
III. Maturity and Stability Period (2006 - 2015)
2008
The company fully implemented the Total Quality Management (TQM) system, with all employees actively participating in the quality management process. Through continuous improvement of production processes, strengthening of raw material inspection and finished product sampling, product quality was further enhanced. In that year, the company achieved remarkable social and economic benefits and was honored as a "Private Joint-stock Enterprise with a Large Tax Payment" by the county government.
2010
Zhejiang Kangle Capsule Co., Ltd. had become a key backbone enterprise in the production of hollow capsules in Xinchang (National Medicine Approval Number F20020048). The company continued to increase its investment in research and development and successfully developed new products such as axial, circumferential, and directional two-color printed capsules, meeting the special needs of different customers. At the same time, the company strengthened cooperation and exchanges with domestic and foreign pharmaceutical enterprises, and its products began to be exported to some Southeast Asian countries.
2015
The number of company employees reached 150, including 10 junior college students and 20 secondary vocational school students. The talent team continued to grow and the quality significantly improved. The company had 12 hollow capsule production lines, with an annual production capacity stable at around 12 billion capsules. The products covered various colors and specifications of hollow capsules such as 00#, 0#, 1#, 2#, 3#, and 4#, occupying an important position in the domestic market.
IV. Innovation and Development Period (2016 - Present)
2018
The company actively responded to the call of the national pharmaceutical industry for innovative development and increased investment in intelligent production. It introduced advanced automated production equipment and intelligent control systems, realizing the automation of some production processes, which not only improved production efficiency but also further enhanced the stability of product quality.
2020
During the special period of the COVID-19 pandemic, the company demonstrated strong social responsibility. On the one hand, it strictly ensured the production and supply of hollow capsules to guarantee the normal production and operation of pharmaceutical enterprises. On the other hand, it actively participated in the production and allocation of anti-epidemic materials, contributing to the fight against the epidemic. Meanwhile, the company continued to deepen technological innovation and developed more environmentally friendly and safer hollow capsule production processes.
2025 (Prospect)
Zhejiang Kangle Capsule Co., Ltd. plans to further enhance its internationalization level, obtain certifications in mainstream international pharmaceutical markets such as Europe and the United States, and establish sales channels. It will continue to increase investment in research and development, explore the application possibilities of hollow capsules in new dosage forms and new uses, and strive to become a leading hollow capsule supplier. With first-class product quality, moderate price advantages, and good after-sales service, it aims to work hand in hand with more domestic and foreign pharmaceutical enterprises to create a better future for the pharmaceutical industry.